Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
NeuroVive Signs Mitochondrial Medicine Research Agreement With US key Opinion Leader 2017-01-23 16:03
ResMed and BMC/3B Medical Settle Global Litigation 2017-01-21 07:06
Merck and Genea Open Centre of Excellence for Fertility 2017-01-20 19:59
Dubai's International Humanitarian City to Triple in Size 2017-01-20 03:16
IPMC Hosts its First International Conference - "Beyond Precision Medicine: From Womb to Heaven" 2017-01-19 22:00
Disruptive Innovations in Global Behavioral Health Market Create Double-Digit Growth for Digital Applications 2017-01-19 21:27
Ceva Completes Deal to Acquire Portfolio of Merial Swine and Cattle Vaccines and Nonsteroidal Anti-inflammatories from Boehringer Ingelheim 2017-01-19 21:24
NeuroVive Presents Positive Preclinical Data in Hepatocellular Cancer at HCC Summit 2017-01-19 17:58
China's Medical Device Industry is Ushering in a Rare Policy-intensive Promotional Period; Policy Boosts Medical Device Localization Process 2017-01-18 19:25
Value-based Care and Digital Patient Engagement Drive Growth Opportunities for Western Europe Hospital IT 2017-01-18 19:01
CPhI SEA -- the leading pharma event in South East Asia - adds 6 new features 2017-01-18 09:00
BookDoc Makes Medical Tourism More Enjoyable with TripAdvisor 2017-01-18 08:00
Merck Opens Production Facility Exclusively for Meglumine in Spain 2017-01-17 21:00
NeoTrident Offers NetDimensions Talent Suite to China's Fast-Growing Life Sciences Industry 2017-01-17 09:00
Lima Corporate Announces New Advisory Board Member 2017-01-16 22:00
Infinitus Functional Lipids Technology Honored with China's National Science and Technology Progress Award 2017-01-16 15:21
Golden Meditech's Controlling Shareholder Proposed a Voluntary Conditional Cash Offer at HK$1.25 per share 2017-01-13 22:05
CPhI: Pharma in South East Asia wins through Innovation, M&A, JVs and strategic Partnerships to spur Markets Integration 2017-01-13 17:52
Quarz Capital Management, Ltd. Sends Open Letter to International Healthway Corporation to Engage on the Proposals to Unlock a Total Potential Return of >40% in IHC's Share Price through the Sale of Non-Core Assets and Refocus on Key Markets. 2017-01-13 09:15
Strong Intellectual Property Strategy in Companion Diagnostics Creates Growth Opportunities 2017-01-12 21:40
1 753 754 755 756 757 803